Advertisement
UK markets closed

  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     

  • FTSE 250

    19,391.30
    -59.37 (-0.31%)
     

  • AIM

    745.67
    +0.38 (+0.05%)
     

  • GBP/EUR

    1.1615
    -0.0068 (-0.58%)
     

  • GBP/USD

    1.2370
    -0.0069 (-0.55%)
     

  • Bitcoin GBP

    51,973.51
    +1,153.88 (+2.27%)
     

  • CMC Crypto 200

    1,382.23
    +69.61 (+5.30%)
     

  • S&P 500

    4,960.57
    -50.55 (-1.01%)
     

  • DOW

    37,886.43
    +111.05 (+0.29%)
     

  • CRUDE OIL

    83.04
    +0.31 (+0.37%)
     

  • GOLD FUTURES

    2,410.10
    +12.10 (+0.50%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     

  • DAX

    17,737.36
    -100.04 (-0.56%)
     

  • CAC 40

    8,022.41
    -0.85 (-0.01%)
     
Property:

11 beautiful homes with glorious garden rooms

Investing in a home with a garden room will enable you to enjoy your outside space whatever the weather

Roche's Foundation Medicine wins FDA blessing for new cancer test

Reuters

ZURICH (Reuters) - Roche (ROG.S) on Monday said its Foundation Medicine (FMI.O) unit won U.S. Food and Drug Administration (FDA) approval for a test to help doctors understand the genetic profile of patients' tumours and guide them to effective therapies.

Roche, which owns 58 percent of Foundation, is hoping to use the FoundationOne CDx assay to personalise cancer care, where treatment is better tailored to the specific molecular characteristics of each patient's disease.

(Reporting by John Miller)